Senior Clinical Trial Associate at HeartFlow

San Francisco, California, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Medical Technology, Healthcare InnovationIndustries

Requirements

Candidates should possess an interest in clinical research, a sharp eye for detail, outstanding organizational skills, and a professional demeanor for both internal and external interactions. Strong editing and proofreading skills, excellent technical and computer skills, the ability to learn and be flexible, and excellent time-management skills to effectively prioritize competing deadlines are also required.

Responsibilities

The Senior Clinical Trial Associate will manage multiple Investigator Initiated Clinical studies, including collecting regulatory documents, assisting with contracting, tracking study progress, serving as a point of contact, participating in meetings, and maintaining study databases and files. They will also perform site management activities for HeartFlow sponsored study sites, assist with study start-up activities, provide day-to-day clinical project support, manage and track finances against study budgets, and assist with the development of study tools and documents.

Skills

Clinical Trial Management

Regulatory Documents

Contracting

Project Management

Communication

Organization

Proofreading

Time Management

HeartFlow

Non-invasive cardiac testing for heart disease

About HeartFlow

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.

Redwood City, CaliforniaHeadquarters

2010Year Founded

$858.5MTotal Funding

SERIES_FCompany Stage

HealthcareIndustries

501-1,000Employees

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Risks

Emerging AI-driven competitors could threaten HeartFlow's market share.

Algorithmic bias in AI models could lead to inaccurate diagnoses.

Integration into healthcare systems may face resistance due to complexity and cost.

Differentiation

HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.

HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.

HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Upsides

HeartFlow closed a $215 million Series F funding round in April 2023.

The global non-invasive cardiac imaging market is projected to grow significantly.

HeartFlow's technology aligns with the trend towards value-based care in healthcare.

Land your dream remote job 3x faster with AI

Try Jobo Free